2 results
Approved WMOCompleted
Primary ObjectiveThe primary objective of this double-blind, randomized, placebo-controlled, Phase 3 study is to assess the efficacy and safety of treatment with Kiacta in adult patients with AA amyloidosis. Efficacy will be assessed by the time…
Approved WMORecruiting
In this study, we look at how safe the new medicinal product rusfertide is for the treatment of Polycythemia vera. And how well it works.